XML 90 R78.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION - Summary of Reportable Segments (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 01, 2023
segment
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
segment
Jun. 30, 2022
USD ($)
Segment Reporting [Abstract]          
Number of reportable segments | segment       3  
Number of operating segments realigned | segment 2        
Financial information regarding the Company's reportable segments          
Net Sales   $ 895,906 $ 844,543 $ 1,755,973 $ 1,689,475
Acquisition related costs   0 0 (255) 0
Restructuring initiatives   (1,943) (428) (13,467) (719)
Net unrealized investment gain (loss)   2,891 (483) 3,079 (2,574)
Depreciation and amortization   (62,267) (58,552) (121,526) (117,217)
Interest expense   (9,688) (11,982) (19,916) (20,912)
Interest income   648 989 1,320 1,277
Income before Income Taxes   110,878 89,471 184,147 176,097
Optimization Initiative          
Financial information regarding the Company's reportable segments          
Restructuring initiatives   (1,943) 0 (13,483) 0
Prior Year Initiatives          
Financial information regarding the Company's reportable segments          
Restructuring initiatives   0 (428) 16 (719)
Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   390,700 340,231 746,746 682,693
Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   329,587 317,667 655,976 626,747
Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   175,619 186,645 353,251 380,035
Operating segment          
Financial information regarding the Company's reportable segments          
Net Sales   906,885 858,329 1,776,773 1,716,437
Operating segment | Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   391,010 345,369 747,121 692,041
Adjusted EBITDA   125,866 111,006 235,164 226,558
Restructuring initiatives   (434) 0 (1,565) 0
Operating segment | Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   338,404 323,794 671,742 639,162
Adjusted EBITDA   43,100 41,230 80,305 75,780
Restructuring initiatives   (479) (423) (9,770) (534)
Operating segment | Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   177,471 189,166 357,910 385,234
Adjusted EBITDA   27,772 21,354 53,780 45,537
Restructuring initiatives   (440) (5) (962) (185)
Intersegment          
Financial information regarding the Company's reportable segments          
Net Sales   10,979 13,786 20,800 26,962
Intersegment | Aptar Pharma          
Financial information regarding the Company's reportable segments          
Net Sales   310 5,138 375 9,348
Intersegment | Aptar Beauty          
Financial information regarding the Company's reportable segments          
Net Sales   8,817 6,127 15,766 12,415
Intersegment | Aptar Closures          
Financial information regarding the Company's reportable segments          
Net Sales   1,852 2,521 4,659 5,199
Corporate Non-Segment          
Financial information regarding the Company's reportable segments          
Adjusted EBITDA   (15,501) (13,663) (34,337) (31,633)
Restructuring initiatives   $ (590) $ 0 $ (1,170) $ 0